Literature DB >> 2531551

Altered microvascular reactivity in streptozotocin-induced diabetes in rats.

M A Hill1, R G Larkins.   

Abstract

This study examined the effect of short-term streptozotocin-induced diabetes in rats on the response of cremaster muscle arterioles to angiotensin II (ANG II) and vasodilatory prostaglandins. Topically applied ANG II (10(-10) to 10(-6) M) caused significantly greater vasoconstriction of third-order arterioles in diabetic animals in comparison with controls. For example, in response to 10(-6) M ANG II arterioles of the diabetic animals constricted to 43 +/- 10% of basal diameter compared with controls' 67 +/- 6% (P less than 0.05). Furthermore, the magnitude of the secondary vasodilatation after ANG II-induced constriction was decreased in diabetic animals (108 +/- 4 and 131 +/- 9%, P less than 0.025). Cyclooxygenase inhibition resulted in marked arteriolar constriction, with this effect being less evident in diabetic animals. In response to indomethacin (2.8 x 10(-5) M), arterioles of the diabetic animals constricted to 84 +/- 7% of basal diameter compared with 56 +/- 4% in controls (P less than 0.01). Arterioles of the diabetic animals were less responsive to exogenous prostaglandin I2 (PGI2) and PGE2 (10(-12) to 10(-6) M) despite evidence of increased in vitro PGI2 production. The data demonstrate potentiation of the vasoconstrictor response and a diminution of the secondary vasodilator response to ANG II in experimental diabetes. These alterations may be due, in part, to decreased responsiveness of skeletal muscle arterioles to vasodilatory prostaglandins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2531551     DOI: 10.1152/ajpheart.1989.257.5.H1438

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Rho-kinase and the nitric oxide pathway modulate basilar arterial reactivity to acetylcholine and angiotensin II in streptozotocin-induced diabetic mice.

Authors:  Md Zahorul Islam; Cuong Van Dao; Atsushi Miyamoto; Mitsuya Shiraishi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-06-27       Impact factor: 3.000

2.  Role of vascular adrenergic mechanisms in the haemodynamic and PGI2 stimulating effects of angiotensin in diabetic dogs.

Authors:  M Z Koltai; I Pósa; E Kocsis; P Rösen; G Pogátsa
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

3.  Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analogue iloprost.

Authors:  M A Cotter; K C Dines; N E Cameron
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

4.  Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization.

Authors:  N E Cameron; M A Cotter; K C Dines; E K Maxfield
Journal:  Diabetologia       Date:  1993-06       Impact factor: 10.122

5.  Mechanisms in rabbit aorta for hyperglycaemia-induced alterations in angiotensin II and norepinephrine effects.

Authors:  D A Simmons; A I Winegrad
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

6.  Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats.

Authors:  N E Cameron; M A Cotter; K Dines; A Love
Journal:  Diabetologia       Date:  1992-10       Impact factor: 10.122

7.  Insulin does not regulate vascular smooth muscle Na+, K(+)-ATPase activity in rabbit aorta.

Authors:  D A Simmons; A I Winegrad
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.